in September. Pennsylvania Attorney General Josh Shapiro was one of the seven whose filing called the top executive pre-bankruptcy bonuses “excessive.”
In 1970, 309 “addict-patients” at the city-run Philadelphia General Hospital spoke about their drug abuse. One-in-five said they abused Numorphan at least once, according to the 1972 published report on the findings. In 1982, Endo’s then-owner DuPont withdrew Numorphan tablets from the market for “commercial reasons” and amid “anecdotal reports of abuse by injection,” according to a FDA review of oxymorphone’s regulatory history.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: